Artemisinin 62.5 mg + Piperaquine Phosphate 375 mg
Class: Artemisinin-based combination antimalarial (ACT)
Manufacturer: Ajanta Pharma Limited
Dosage Form: Film-coated oral tablets (pack of 4 tablets)
Similar Brands:
Uses:
-
Treatment of uncomplicated malaria, especially infections caused by Plasmodium falciparum
-
Used where resistance to older antimalarials is suspected
Dosage:
Dose depends on body weight and local treatment guidelines.
Typical adult regimen (≥35 kg):
-
2 tablets once daily for 2 consecutive days (total 4 tablets)
Take with water, preferably after food. Follow the exact dosing instructions provided by a healthcare professional.
Side Effects:
Common
-
Nausea, vomiting
-
Abdominal discomfort
-
Headache
-
Dizziness
Less common / serious
-
Palpitations or irregular heartbeat
-
Fatigue or weakness
-
Skin rash or allergic reactions
-
QT interval prolongation (heart rhythm disturbance)
Warnings & Precautions:
-
Complete the full course even if symptoms improve.
-
Use cautiously in patients with heart rhythm disorders.
-
Avoid use with other medicines that prolong QT interval.
-
Not recommended for severe or complicated malaria (requires hospital treatment).
-
Caution in liver or kidney impairment.
-
If vomiting occurs soon after taking the dose, seek medical advice.
Pregnancy & Lactation:
-
Use during pregnancy only if clearly needed and prescribed.
-
Safety in breastfeeding is not fully established — consult a healthcare professional.
Drug Interactions:
-
Medicines that prolong QT interval (e.g., certain antibiotics, antipsychotics)
-
Other antimalarial medicines
-
Liver enzyme-affecting drugs
-
Grapefruit or grapefruit juice (may affect drug levels)
Contraindications:
-
Hypersensitivity to artemisinin, piperaquine, or any component
-
History of significant cardiac rhythm disorders
-
Severe malaria requiring emergency management
Price: Ksh 738/-
Notes:
Pack Size: 4s